Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Hygea Vct LSE:HYG London Ordinary Share GB0031256109 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 43.00p 0 05:00:01
Bid Price Offer Price High Price Low Price Open Price
41.00p 45.00p 43.00p 43.00p 43.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments -0.12 -1.50 3.5

Hygea Vct (HYG) Latest News

More Hygea Vct News
Hygea Vct Takeover Rumours

Hygea Vct (HYG) Share Charts

1 Year Hygea Vct Chart

1 Year Hygea Vct Chart

1 Month Hygea Vct Chart

1 Month Hygea Vct Chart

Intraday Hygea Vct Chart

Intraday Hygea Vct Chart

Hygea Vct (HYG) Discussions and Chat

Hygea Vct Forums and Chat

Date Time Title Posts
13/9/201807:58HYGEA VCT : medical technology company VCT189
17/1/200519:21Honeygrove Group - was Propan Homes514
16/10/200315:41HYG Charts2

Add a New Thread

Hygea Vct (HYG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Hygea Vct trades in real-time

Hygea Vct (HYG) Top Chat Posts

Hygea Vct Daily Update: Hygea Vct is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker HYG. The last closing price for Hygea Vct was 43p.
Hygea Vct has a 4 week average price of 43p and a 12 week average price of 43p.
The 1 year high share price is 50.65p while the 1 year low share price is currently 42.50p.
There are currently 8,115,376 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Hygea Vct is £3,489,611.68.
rivaldo: Interims out - NAV down to 69.1p due to the decline in SCLP's share price. SCLP is up some 10% since 30/6, so I would expect NAV to be up nearer say 71p now: Http:// Hallmarq is still progressing very well. It's surely just a matter of time before it IPO's on AIM, at which point I'd expect NAV serious upside. I'm also hopeful for the £450k carrying value in AIM-quoted ODX - this could be worth a lot more in a few months' time with decent news flow.
timbo003: Tristel worth keeping an eye on. Up around 20% today following a trading update and now up around 65% this year, they accounted for 0.6p/share of Hygea's NAV at year end, so that should be more like 1p/share now.
rivaldo: Results just out: Http:// 97p NAV now, so the share price is at a substantial discount. SCLP will either be a massive winner or a total flop I suppose. But Hallmarq looks better and better imo. It made £648k PBT to 31/8/13 at a pretty reasonable £10m valuation - and that's before any contribution from the now-launched Petvet, which has a massive global market. I wish I could buy shares directly in Hallmarq. And Eykona suddenly looks like being a bit of a goer since it's suddenly been discovered at the heart of the 3D printing industry: "Eykona became aware of the opportunity within the 3D printing market to develop its camera as the world's first high resolution 3D scanner for the consumer market." If progress in the USA continues, who knows what it might become worth?
rivaldo: ODX has roughly doubled over the last few weeks. At 30/6/13 HYG's holding was worth £437k, so this must now be worth around £850k or so - quite a significant increase in the context of HYG's £5.4m m/cap. EKF is also rising nicely, to 38p now and a £475k worth to HYG. HYG is developing nicely, with SCLP, Hallmarq, ODX and EKF providing a variety of supports for the share price and NAV.
timbo003: Today's RNS from EKF sounds more than just interesting. At the last full valuation (June 30th), EKF accounted for 4p/share of Hygea's NAV (with the underlying share price for EKF at around 26p/share), at close on Friday, EKF were around 35p/share, so presumably they currently account for around 5.5p/share of Hygea's NAV. I suspect EKF will have an "up" day today. Here's the link to their summary quote page:
rivaldo: Terrific RNS from SCLP today, with a subsequent share price jump to 40p now: Http://
timbo003: It was at the Scancell Investor day on Tuesday, there are a number of write ups of the event on the LSE Scancell BB, my own version of events is on the ADVFN Scancell thread After the meeting I had a chance to chat to a few people, including: a couple of ADVFNers, Lucius (chief cheese fund manager for the Oxford VCTs), James (Chairman and fund manager at Hygea VCT) and Chris (market maker at Panmure). The Oxford VCTs took up their allocation in the open offer, Hygea did not (for technical reasons), both Lucius and James seemed impressed with the Scancell BOD and with progress. I do not think they will be selling. Note also that the Hygea share price (which usually tracks the Scancell share price) did not follow Scancell down yesterday, which I suspect was after all the praise that James was showering on Hallmarq (in reponse to a question from me). He was incredibly bullish on Hallmarq, but he says the problem is assigning a value, none of the current PE valuations are really appropriate.
rivaldo: Cheers sbp, good news. SCLP's share price suffered after the recent fundraising, but with a bit of director buying has recovered nicely to just over 35p so far. It's too hot for me to be bothered to work out HYG's current NAC precisely! But I'd judge it to be around 95p-100p at present holding a finger in the air, so the share price remains at a large discount.
rivaldo: Timbo, I hope you don't mind me copying here your poat from T.M.F re HYG as it's a useful prompter - though I think Freehand is actually now the second biggest investment, with EKF perhaps third (as an aside, personally I can't see much upside for EKF at the current high valuation for some time to come) : "There is a useful AGM report for EKF Diagnostics over on the Sharesoc forum (you need to register to read, but its free): EKF are the second largest Aim quoted investmment in the Hygea portfolio, summary details are here EKF was on Hygea's books at £354K at 31st December and the share price is now more or less where it was at the end of the year (30p), so it contributes around 3.5p/share of Hygea's NAV (adjusted for management incentive). Interesting to read that there were two approaches for EKF last year, one of which was "serious" from a large international player and the possible reasons why it did not proceed. Perhaps it's only a matter of time before EKF get taken out. Should this occur, it would represent a significant liquidy event and profit for Hygea (they bought their stake for £260K)."
timbo003: rivaldo By my calculations, if SCLP share price is 49p, then NAV for Hygea (using Hygea's own methodology of taking the performance incentive into account) would be 120p (not 128p). The reasoning goes like this: Without correcting for the performance incentive, every 1p increase in SCLP increases Hygea NAV by 1.82p With correction for the performance incentive (which kicks now NAV total return >80p), every 1p increase in SCLP increases Hygea NAV by 1.51p (i.e 1.82 *5/6) Taking Hygea's own figures at the last update: i.e. SPLC at 32p gives a Hygea NAV of 94p, then it follows that by applying a 1.51X muliplier, that a SPLC share price of 49p, corresponds to a Hygea NAV of 120p (approx). Could someone else carefully check over the maths and performance incentive detail please, as this is an important point now SPLC is charging ahead, I'll be delighted to be corrected if I've made an error.
Hygea Vct share price data is direct from the London Stock Exchange
Your Recent History
Hygea Vct
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181210 14:51:14